Effect of ivabradine vs atenolol on heart rate and effort tolerance in patients with mild to moderate mitral stenosis and normal sinus rhythm
Journal of Cardiac Failure,  Clinical Article

Parakh N et al. – Ivabradine is more effective than atenolol for effort related symptoms in patients with mild–moderate mitral stenosis and normal sinus rhythm.

Methods
  • Fifty patients with mild–moderate mitral stenosis in sinus rhythm were randomized to receive ivabradine or atenolol for 4 weeks each in an open–label, randomized, crossover design trial.
  • A 24–hour Holter and treadmill test was performed at baseline and after each active treatment period.
  • In the first treatment period, 23 patients were allocated to ivabradine (22 analyzed), and 27 were allocated to atenolol (26 analyzed).
  • In the second period, all 48 patients were analyzed.

Results
  • Ivabradine increased the mean total exercise time to 500.7 seconds (SD 99.7) from a baseline of 410.3 seconds (SD 115.4), and atenolol increased it to 463.7 seconds (SD 113.1).
  • The point estimate (absolute difference between ivabradine and atenolol) was 35.27 seconds (95% CI 15.24–55.20; P = .0009).
  • The point estimate for decrease in the maximum exercise heart rate and mean heart rate were 7.64/min (95% CI 0.37–15.9; P = .04) and 5.61/min (95% CI 2.51–8.71; P = .0007), respectively.

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

    Currently, there are no available articles.

Your Unread Messages in Nurse Practitioner

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Nurse Practitioner Articles

Indexed Journals in Nurse Practitioner: Journal of the American Academy of Nurse Practitioners, Holistic Nursing Practicemore

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close